Target intelligence / Profile preview

Electrical signaling in bone tissue

Molecular classification
Ion channel (voltage-gated ion channels), Cellular signaling pathway (Wnt/β-catenin, TGF-β, calcium signaling), Other (piezoelectric materials, electroactive extracellular matrix)
01

Overview

Electrical signaling in bone tissue refers to how bones generate and respond to endogenous and exogenous electrical and electromagnetic fields, largely through electroactive material properties (piezoelectricity, dielectric, etc.) and the activation of cell membrane ion channels and signaling cascades. Electrical or electromagnetic stimulation can regulate membrane potential, induce ionic flux (especially calcium), and activate signaling pathways essential for bone cell proliferation, differentiation, and mineralization, notably the Wnt/β-catenin and TGF-β pathways. These processes are central to bone repair, remodeling, and the effectiveness of bone tissue engineering and regenerative therapies. As a concept, "electrical signaling in bone tissue" is not a single molecular target but rather includes a network of molecular mechanisms and electrosensitive elements involved in bone physiology and healing[3][1][2][5]. This entry is not a suitable canonical molecular target, but is an important conceptual therapeutic area.

Other names
Bioelectrical signaling in boneBone bioelectricityElectrical stimulation in bone tissue
02

Mechanism of action

Modulation of voltage-gated ion channel activity. Regulation of intracellular calcium influx. Stimulation of Wnt/β-catenin pathway. Activation of TGF-β signaling. Influence on osteoblast and osteoclast activity via cellular polarization and membrane potential changes[3][1][2]

03

Biological functions

Signal transductionBone regenerationCell proliferationCell differentiationOsteogenesis (bone formation)Bone remodeling and repair
04

Disease associations

Bone fracture healingOsteoporosisBone defectsImpaired bone tissue engineering
05

Safety considerations

Non-specificity and difficulty in targeting only bone tissuePotential off-target tissue stimulationLack of understanding of long-term effects and molecular mechanisms[2]
06

Biomarkers

Gene expression changes: ALP (alkaline phosphatase), OCN (osteocalcin), COL1A1, RUNX2, CCND1, CCNE1Calcium fluxUpregulation of Wnt pathway components (Wnt1, LRP6, β-catenin)

Beyond the preview

Go deeper on Electrical signaling in bone tissue.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Electrical signaling in bone tissue.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call